These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8268343)

  • 1. Vascular catheter-related bloodstream infection due to Acinetobacter johnsonii (formerly Acinetobacter calcoaceticus var. lwoffi): report of 13 cases.
    Seifert H; Strate A; Schulze A; Pulverer G
    Clin Infect Dis; 1993 Oct; 17(4):632-6. PubMed ID: 8268343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and microbiological characteristics of bacteremia caused by Acinetobacter lwoffii.
    Ku SC; Hsueh PR; Yang PC; Luh KT
    Eur J Clin Microbiol Infect Dis; 2000 Jul; 19(7):501-5. PubMed ID: 10968320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nosocomial bacteremia due to Acinetobacter calcoaceticus.
    Raz R; Alroy G; Sobel JD
    Infection; 1982; 10(3):168-71. PubMed ID: 7107014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex.
    Chopra T; Marchaim D; Johnson PC; Awali RA; Doshi H; Chalana I; Davis N; Zhao JJ; Pogue JM; Parmar S; Kaye KS
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4630-5. PubMed ID: 24890594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacteremia with Acinetobacter species--clinicopathological characteristics of 27 cases].
    Kurosu I
    Kansenshogaku Zasshi; 1995 Aug; 69(8):895-902. PubMed ID: 7594782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of Acinetobacter baumannii in blood cultures.
    Seifert H; Baginski R
    Zentralbl Bakteriol; 1992 Jul; 277(2):210-8. PubMed ID: 1520980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcomes of bacteremia caused by Acinetobacter species other than A. baumannii: comparison with A. baumannii bacteremia.
    Choi SH; Choo EJ; Kwak YG; Kim MY; Jun JB; Kim MN; Kim NJ; Jeong JY; Kim YS; Woo JH
    J Infect Chemother; 2006 Dec; 12(6):380-6. PubMed ID: 17235644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acinetobacter calcoaceticus septicemia in patients with cancer.
    Rolston K; Guan Z; Bodey GP; Elting L
    South Med J; 1985 Jun; 78(6):647-51. PubMed ID: 4001997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acinetobacter calcoaceticus sepsis in children with malignancies.
    Fuchs GJ; Jaffe N; Pickering LK
    Pediatr Infect Dis; 1986; 5(5):545-9. PubMed ID: 3463939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior use of four invasive procedures increases the risk of Acinetobacter baumannii nosocomial bacteremia among patients in intensive care units: a systematic review and meta-analysis.
    Zhou HY; Yuan Z; Du YP
    Int J Infect Dis; 2014 May; 22():25-30. PubMed ID: 24607429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-acquired bacteremias from tunneled central intravenous lines: results from studies of a single vendor.
    Brown RB; Cipriani D; Schulte M; Corl A; Pieczarka R
    Am J Infect Control; 1994 Jun; 22(3):149-51. PubMed ID: 7943925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of reduced tigecycline susceptibility on clinical outcomes of Acinetobacter bacteremia.
    Chang YY; Liu YM; Liu CP; Kuo SC; Chen TL;
    J Microbiol Immunol Infect; 2018 Feb; 51(1):148-152. PubMed ID: 29050749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse.
    Hanna H; Afif C; Alakech B; Boktour M; Tarrand J; Hachem R; Raad I
    Infect Control Hosp Epidemiol; 2004 Aug; 25(8):646-9. PubMed ID: 15357155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous catheter-related infections.
    Salzman MB; Rubin LG
    Adv Pediatr Infect Dis; 1995; 10():337-68. PubMed ID: 7718211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure.
    Liou BH; Lee YT; Kuo SC; Liu PY; Fung CP
    Antimicrob Agents Chemother; 2015; 59(6):3637-40. PubMed ID: 25824230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acinetobacter pittii isolated more frequently than Acinetobacter baumannii in blood cultures: the experience of a French hospital.
    Pailhoriès H; Tiry C; Eveillard M; Kempf M
    J Hosp Infect; 2018 Jul; 99(3):360-363. PubMed ID: 29577994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acinetobacter calcoaceticus-baumannii complex bacteremia: analysis of 82 cases.
    Lin SY; Wong WW; Fung CP; Liu CE; Liu CY
    J Microbiol Immunol Infect; 1998 Jun; 31(2):119-24. PubMed ID: 10596990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital.
    Pujol M; Hornero A; Saballs M; Argerich MJ; Verdaguer R; Cisnal M; Peña C; Ariza J; Gudiol F
    J Hosp Infect; 2007 Sep; 67(1):22-9. PubMed ID: 17719678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.
    Glew RH; Moellering RC; Kunz LJ
    Medicine (Baltimore); 1977 Mar; 56(2):79-97. PubMed ID: 846390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The patient with intravascular lines.
    Byl B
    Acta Clin Belg; 1998 Dec; 53(6):355-9. PubMed ID: 10023144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.